Utility of Risk Models in Decision Making After Radical Prostatectomy: Lessons from a Natural History Cohort of Intermediate- and High-Risk Men-Reference-Cited by-同舟云学术

Utility of Risk Models in Decision Making After Radical Prostatectomy: Lessons from a Natural History Cohort of Intermediate- and High-Risk Men

Published:2016-03 Issue:3 Volume:69 Page:496-504
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Ross Ashley E.,Yousefi Kasra,Davicioni Elai,Ghadessi Mercedeh,Johnson Michael H.,Sundi Debasish,Tosoian Jeffery J.,Han Misop,Humphreys Elizabeth B.,Partin Alan W.,Walsh Patrick C.,Trock Bruce J.,Schaeffer Edward M.

Publisher

Elsevier BV

Subject

Urology

Reference33 articles.

1. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate;Stamey;N Engl J Med,1987

2. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up;Schröder;Lancet,2014

3. Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations;Walsh;Prostate,1983

4. An anatomical approach to the surgical management of the dorsal vein and Santorini's plexus during radical retropubic surgery;Reiner;J Urol,1979

5. Active surveillance program for prostate cancer: an update of the Johns Hopkins experience;Tosoian;J Clin Oncol,2011

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy;Journal of Urology;2024-04

2. On the Road to Accurate Protein Biomarkers in Prostate Cancer Diagnosis and Prognosis: Current Status and Future Advances;International Journal of Molecular Sciences;2021-12-17

3. Predicting Cancer-Specific Survival Among Patients With Prostate Cancer After Radical Prostatectomy Based on the Competing Risk Model: Population-Based Study;Frontiers in Surgery;2021-11-26

4. Lead-time bias does not falsify the efficacy of early salvage radiotherapy for recurrent prostate cancer;Radiotherapy and Oncology;2021-01

5. Event-Free Survival, a Prostate-Specific Antigen–Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation;Journal of Clinical Oncology;2020-09-10